Making Treatment Free Remission "Feasible" in Low- and Middle- Income Countries- Outcomes, Patterns of Failure and Compliance of Treatment Free Remission (TFR) in Chronic Myeloid Leukemia (CML) from a Tertiary Care Cancer Centre in India

被引:0
|
作者
Punatar, Sachin [1 ,2 ]
Jindal, Nishant [1 ,3 ]
Gokarn, Anant [1 ,2 ]
Mirgh, Sumeet [1 ,3 ]
Chichra, Akanksha [1 ,2 ,4 ]
Nayak, Lingaraj [1 ,2 ]
Bagal, Bhausaheb [1 ,2 ]
Hande, Vinod [5 ]
Chavan, Swapnil [5 ]
Kumbhalwar, Komal [2 ]
Menon, Hari [6 ]
Khattry, Navin [1 ,3 ]
机构
[1] Homi Bhabha Natl Inst, Mumbai, India
[2] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc ACTREC, Navi Mumbai, India
[3] Tata Mem Hosp, ACTREC, Dept Med Oncol, Navi Mumbai, India
[4] Tata Mem Hosp, Dept Pediat Oncol, Mumbai, India
[5] Tata Mem Hosp, ACTREC, Navi Mumbai, India
[6] St Johns Natl Acad Hlth Sci, Bengaluru, India
关键词
D O I
10.1182/blood-2024-209885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3161 / 3162
页数:2
相关论文
共 16 条
  • [1] Real World Data of Treatment Free Remission (TFR) in Patients With Chronic Myeloid Leukemia (CML) Treated at a Tertiary Care Oncology Center in India
    Sarma, Rup
    Thorat, Jayashree
    Nayak, Lingraj
    Jain, Hashmukh
    Sengar, Manju
    Banavali, Sripad
    Bagal, Bhausaheb
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S298 - S299
  • [2] Real World Outcomes with Treatment Free Remission in Chronic Myeloid Leukemia-Experience from a Tertiary Care Cancer Centre
    Sarma, Rup Jyoti
    Kashyap, Lakhan
    Srikanth, Anne
    Mondal, Tanmoy
    Kashyap, Yashwant
    Nandhana, Ravindra
    Bondili, Suresh Kumar
    Bonda, Avinash
    Nayak, Lingaraj
    Chatterjee, Gaurav
    Jain, Hashmukh
    Patkar, Nikhil Vijay
    Tembhare, Prashant
    Subramanian, Papagudi
    Gujral, Sumeet
    Sengar, Manju
    Menon, Hari
    Nair, Reena
    Bagal, Bhausaheb
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (04) : 564 - 572
  • [3] Retrospective Study of Treatment Free Remission in Patients with Chronic Myeloid Leukaemia(CML) Treated at Tertiary Care Oncology Centre from India
    Verma, Megha
    Halder, Rohan
    Singh, Reema
    Mehta, Pallavi
    Agrawal, Narendra
    Ahmed, Rayaz
    Bhurani, Dinesh
    BLOOD, 2022, 140 : 12222 - 12222
  • [4] Impact of Treatment Cessation on Overall Disease Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Attempting Treatment-Free Remission (TFR): Findings from Enestfreedom and Enestop
    Saglio, Giuseppe
    Hughes, Timothy P.
    Hochhaus, Andreas
    Kim, Dong-Wook
    Giles, Francis J.
    Radich, Jerald P.
    Ross, David M.
    Gopalakrishna, Prashanth
    Deng, Weiping
    Fellague-Chebra, Rafik
    Acharya, Sandip
    Mahon, Francois-Xavier
    BLOOD, 2017, 130
  • [5] RESULTS FROM ENESTFREEDOM: TREATMENT-FREE REMISSION (TFR) FOLLOWING FRONTLINE NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
    Saglio, G.
    Masszi, T.
    Gomez Casares, M. T.
    Hellmann, A.
    Stentoft, J.
    Conneally, E.
    Garcia Gutierrez, V.
    Gattermann, N.
    Wiktor-Jedrzejczak, W.
    le Coutre, P. D.
    Martino, B.
    Saussele, S.
    Giles, F. J.
    Radich, J. P.
    Ross, D. M.
    Menssen, H. D.
    Deng, W.
    Krunic, N.
    Bedoucha, V.
    Hochhaus, A.
    HAEMATOLOGICA, 2016, 101 : 240 - 241
  • [6] RESULTS FROM ENESTOP: TREATMENT-FREE REMISSION (TFR) FOLLOWING SWITCH TO NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
    Hughes, T. P.
    Boquimpani, C.
    Takahashi, N.
    Benyamini, N.
    Clementino, N. C. D.
    Shuvaev, V.
    Ailawadhi, S.
    Lipton, J. H.
    Turkina, A. G.
    Moiraghi, B.
    Nicolini, F. E.
    Dengler, J.
    Sacha, T.
    Kim, D. W.
    Fellague-Chebra, R.
    Acharya, S.
    Wong, S.
    Jin, Y.
    Mahon, F. X.
    HAEMATOLOGICA, 2016, 101 : 65 - 65
  • [7] Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety
    Lagana, Alessandro
    Scalzulli, Emilia
    Bisegna, Maria Laura
    Carmosino, Ida
    Ielo, Claudia
    Costa, Alessandro
    Torrieri, Lorenzo
    Totaro, Matteo
    Martelli, Maurizio
    Breccia, Massimo
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (08) : 969 - 979
  • [8] Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with frontline nilotinib: Results from the ENESTFreedom study.
    Hochhaus, Andreas
    Masszi, Tamas
    Giles, Francis J.
    Radich, Jerald P.
    Ross, David M.
    Casares, Maria Teresa Gomez
    Hellmann, Andrzej
    Stentoft, Jesper
    Conneally, Eibhlin
    Gutierrez, Valentin Garcia
    Gattermann, Norbert
    Wiktor-Jedrzejczak, Wieslaw
    Le Coutre, Philipp D.
    Martino, Bruno
    Saussele, Susanne
    Menssen, Hans D.
    Deng, Weiping
    Krunic, Nancy
    Bedoucha, Veronique
    Saglio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Identification of Individual Risk Factors for Treatment Free Remission (TFR) Failure in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients: Predictive Models Developed on a Nationwide Clinical and Claim Database
    Chassetuillier, Jules
    Benmerad, Meriem
    Lecoq, Pierre-Louis
    Favier, Romain
    Trancart, Matthieu
    Hayette, Sandrine
    Alcazer, Vincent
    Bouvier, Christophe
    Bollard, Julien
    Lajoinie, Audrey
    Nicolini, Franck E.
    BLOOD, 2023, 142
  • [10] Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study
    Iurlo, Alessandra
    Cattaneo, Daniele
    Artuso, Silvia
    Consonni, Dario
    Abruzzese, Elisabetta
    Binotto, Gianni
    Bocchia, Monica
    Bonifacio, Massimiliano
    Castagnetti, Fausto
    Galimberti, Sara
    Gozzini, Antonella
    Iezza, Miriam
    Latagliata, Roberto
    Luciano, Luigiana
    Maggi, Alessandro
    Miggiano, Maria Cristina
    Pregno, Patrizia
    Rege-Cambrin, Giovanna
    Russo, Sabina
    Scortechini, Anna Rita
    Tafuri, Agostino
    Tiribelli, Mario
    Fava, Carmen
    Rosti, Gianantonio
    Foa, Robin
    Breccia, Massimo
    Saglio, Giuseppe
    FRONTIERS IN ONCOLOGY, 2022, 12